[1] |
JI Xiaojuan, HAN Hao, ZHANG Lixia.
Pathogenic bacteria distribution, drug resistance changes and risk factors of death in patients with acute myeloid leukemia complicated with bloodstream infection
[J]. Tianjin Medical Journal, 2024, 52(2): 167-171.
|
[2] |
ZHOU Jiewen, MA Bingnan, OU Jingyi.
Analysis of changes in bacterial drug resistance and treatment of Salmonella typhimurium enteritis in children
[J]. Tianjin Medical Journal, 2024, 52(12): 1282-1285.
|
[3] |
YU Zhihong, WANG Xiaoqin.
Effects of imperatorin derivatives on the activity and drug resistance protein of alveolar type Ⅱ epithelial cells in COPD
[J]. Tianjin Medical Journal, 2024, 52(11): 1127-1130.
|
[4] |
YU Ping, ZHOU Min, SU Dan.
Construction and validation of chemotherapy resistance prediction model for ovarian cancer
[J]. Tianjin Medical Journal, 2024, 52(11): 1177-1182.
|
[5] |
ZHOU Xinyu, LI Jingmin, ZHANG Ting, JIA Xiuhong.
Study on the mechanism of luteolin reversing multidrug resistance in leukemia K562/ADR cells
[J]. Tianjin Medical Journal, 2023, 51(12): 1321-1325.
|
[6] |
CHEN Cong, WU Yuanzhao, ZHENG Kesi, YING Wenbing, HU Yiren.
Mechanism of Calpain-2 resistance to paclitaxel through induction of epithelial mesenchymal transition in triple-negative breast cancer cells
[J]. Tianjin Medical Journal, 2023, 51(11): 1176-1180.
|
[7] |
WANG Lian, XIAO Jichun, TIAN Yao, LI Xijing, WANG Luyao, WANG Lan, YANG Bohan, ZHANG Rongquan.
Study of persimmon leaf flavonoids ameliorates liver steatosis by activating autophagy and antioxidant stress in NAFLD rats
[J]. Tianjin Medical Journal, 2023, 51(11): 1211-1216.
|
[8] |
YU Kuiyang, LIU Pan, ZHANG Haowen, QIN Tao, HU Mingxing△.
Study on the mechanism of LncRNA ZFAS1 targeting miR-373 to induce cisplatin resistance in hepatocellular carcinoma cells
[J]. Tianjin Medical Journal, 2022, 50(5): 455-460.
|
[9] |
LI Xiyuan, ZHU Zhixin, ZHAO Hailong .
Recent advances in the mechanisms of drug resistance and treatment of
BRAF-mutant melanoma
[J]. Tianjin Medical Journal, 2022, 50(2): 214-219.
|
[10] |
QIAN Qiyu, YUAN Gaili, MA Shanshan, LUO Limei, XU Yu .
Study on the mechanism of quercetin improving gemcitabine resistance in NSCLC through the EMT pathway mediated by miR-101/EZH2 axis
[J]. Tianjin Medical Journal, 2022, 50(2): 125-130.
|
[11] |
LI Zhenjiang, SUN Dechao, KONG Chenxu, GENG Yadong, XU Chenyang, DING Bingqian.
Study on the mechanism of resveratrol reversing temozolomide resistance in glioma cells by regulating Wnt/β-catenin pathway through BRD4
[J]. Tianjin Medical Journal, 2022, 50(10): 1043-1049.
|
[12] |
Effects of miR-a on doxorubicin resistance in breast cancer by targeting Akt/Bcl-.
Effects of miR-34a on doxorubicin resistance in breast cancer by targeting Akt/Bcl-2
[J]. Tianjin Medical Journal, 2022, 50(1): 41-45.
|
[13] |
GUO Ming-ri, ZHU Yu, SUN Hai-bai.
Research progress on drug sensitivity test and drug resistance mechanism of Mycobacterium abscessus complex
[J]. Tianjin Medical Journal, 2021, 49(11): 1216-1222.
|
[14] |
LI Da-huan, XU Liang-bi, LIU Xue-ying, TANG Shan, DENG Chao-nan.
Research progress of TRAIL in the treatment of digestive cancer
[J]. Tianjin Medical Journal, 2021, 49(11): 1228-1232.
|
[15] |
CHEN Yan, NIU Xiu-long, YU Chun-yan, LI Yan, DENG Wei-min.
The mechanisms of IL-17A promoting the cisplatin-based drug resistance of ovarian cancer in vivo
[J]. Tianjin Medical Journal, 2020, 48(3): 187-190.
|